The strategy of JKphArma Galenic Innovation is to improve the actual benefits of drugs by rapidly developing new galenic forms of the existing drugs.

JKphArma Galenic Innovation has a significant portfolio of products under development which are intended to be developed and marketed both directly and in partnership, depending on the type of product and markets. Such partnershipswill help to finance the development of the other products in the portfolio.